Best Practice & Research Clinical Haematology
Volume 22, Issue 4 , Pages 523-528, December 2009

Prognostic factors in AML in relation to (ab)normal karyotype

  • Richard M. Stone, MD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 617 32 2214; Fax: +1 617 632 2933.

Harvard Medical School, Dana-Farber Cancer Institute, 44 Binney Street, Room M1b-17, Boston MA 02115-6084, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00037-1

doi:10.1016/j.beha.2009.07.003

Best Practice & Research Clinical Haematology
Volume 22, Issue 4 , Pages 523-528, December 2009

Article Tools